DK0574457T3 - Antiviral nucleosidkombination - Google Patents

Antiviral nucleosidkombination

Info

Publication number
DK0574457T3
DK0574457T3 DK92905707T DK92905707T DK0574457T3 DK 0574457 T3 DK0574457 T3 DK 0574457T3 DK 92905707 T DK92905707 T DK 92905707T DK 92905707 T DK92905707 T DK 92905707T DK 0574457 T3 DK0574457 T3 DK 0574457T3
Authority
DK
Denmark
Prior art keywords
antiviral nucleoside
combinations
combination
nucleoside combination
antiviral
Prior art date
Application number
DK92905707T
Other languages
English (en)
Inventor
George Robert Painter Iii
Phillip Allen Furman
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of DK0574457T3 publication Critical patent/DK0574457T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK92905707T 1991-03-06 1992-03-05 Antiviral nucleosidkombination DK0574457T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919104740A GB9104740D0 (en) 1991-03-06 1991-03-06 Antiviral nucleoside combination
PCT/GB1992/000389 WO1992015309A1 (en) 1991-03-06 1992-03-05 Antiviral nucleoside combination

Publications (1)

Publication Number Publication Date
DK0574457T3 true DK0574457T3 (da) 2000-04-17

Family

ID=10691101

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92905707T DK0574457T3 (da) 1991-03-06 1992-03-05 Antiviral nucleosidkombination

Country Status (26)

Country Link
US (2) US5234913A (da)
EP (1) EP0574457B1 (da)
JP (1) JP3442773B2 (da)
KR (1) KR100225986B1 (da)
AT (1) ATE185483T1 (da)
AU (1) AU668860B2 (da)
CA (1) CA2105487C (da)
CZ (1) CZ283185B6 (da)
DE (1) DE69230140T2 (da)
DK (1) DK0574457T3 (da)
ES (1) ES2138969T3 (da)
GB (1) GB9104740D0 (da)
GR (1) GR3032299T3 (da)
HK (1) HK1004189A1 (da)
HU (1) HU219492B (da)
IE (1) IE920702A1 (da)
IL (1) IL101145A (da)
MY (1) MY108638A (da)
NZ (1) NZ241842A (da)
PT (1) PT100199B (da)
RU (1) RU2110993C1 (da)
SK (1) SK279767B6 (da)
TW (1) TW199861B (da)
UA (1) UA29429C2 (da)
WO (1) WO1992015309A1 (da)
ZA (1) ZA921660B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6903224B2 (en) 1988-04-11 2005-06-07 Biochem Pharma Inc. Substituted 1,3-oxathiolanes
SE464168B (sv) * 1989-07-19 1991-03-18 Bo Fredrik Oeberg Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt)
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5827727A (en) * 1990-02-01 1998-10-27 Emory University Method of resolution of 1,3-oxathiolane nucleoside enantiomers
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
US6703396B1 (en) 1990-02-01 2004-03-09 Emory University Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
US5914331A (en) * 1990-02-01 1999-06-22 Emory University Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5925643A (en) * 1990-12-05 1999-07-20 Emory University Enantiomerically pure β-D-dioxolane-nucleosides
US6812233B1 (en) * 1991-03-06 2004-11-02 Emory University Therapeutic nucleosides
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
US5817667A (en) * 1991-04-17 1998-10-06 University Of Georgia Research Foudation Compounds and methods for the treatment of cancer
AU1787492A (en) * 1991-05-16 1992-12-30 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
US6177435B1 (en) 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
US20020120130A1 (en) * 1993-09-10 2002-08-29 Gilles Gosselin 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
AU2119695A (en) * 1994-03-16 1995-10-03 Tanox Biosystems, Inc. Synergistic inhibition of hiv-1 infection using a nucleoside reverse transcriptase inhibitor and anti-hiv-1 antibodies
IL115156A (en) * 1994-09-06 2000-07-16 Univ Georgia Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US6391859B1 (en) 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5808040A (en) * 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
MY115461A (en) 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
JP4413996B2 (ja) * 1995-06-07 2010-02-10 エモリー・ユニバーシティ 抗ｂ型肝炎ウィルス活性を有するヌクレオシド
US6544961B1 (en) * 1996-06-25 2003-04-08 Smithkline Beecham Corporation Combinations comprising VX478, zidovudine, FTC and/or 3TC for use in the treatments of HIV
PE87398A1 (es) * 1996-06-25 1999-01-15 Glaxo Group Ltd Combinaciones antivirales
US5753789A (en) * 1996-07-26 1998-05-19 Yale University Oligonucleotides containing L-nucleosides
CA2287370C (en) 1997-03-19 2010-02-09 Emory University Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides
CA2285577A1 (en) 1997-04-07 1998-10-15 Triangle Pharmaceuticals, Inc. Compositions containing mkc-442 in combination with other antiviral agents
US6040434A (en) * 1997-12-01 2000-03-21 Inaba; Tadanobu Aldehyde oxidase inhibitors for treatment of aids
CA2335617C (en) * 1998-06-24 2009-12-15 Emory University Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
CA2563022C (en) 1998-08-12 2010-11-23 Gilead Sciences, Inc. Process for preparing 1,3-dioxolane derivatives
US6979561B1 (en) 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
CN1666742A (zh) 1998-11-02 2005-09-14 三角药物公司 对乙型肝炎病毒的联合治疗
US6436948B1 (en) 2000-03-03 2002-08-20 University Of Georgia Research Foundation Inc. Method for the treatment of psoriasis and genital warts
DE60224592T2 (de) * 2001-03-01 2009-01-29 Abbott Laboratories, Abbott Park Polymorphe und andere kristalline Formen von cis-FTC
UA93354C2 (ru) * 2004-07-09 2011-02-10 Гилиад Сайенсиз, Инк. Местный противовирусный препарат

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
DE3687069T2 (de) * 1985-03-16 1993-03-25 Wellcome Found Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
US4874751A (en) * 1985-03-16 1989-10-17 Burroughs Wellcome Co. Antibacterial treatment
PT82580B (pt) * 1985-05-15 1989-01-17 Wellcome Found Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem
ZA878877B (en) * 1986-11-29 1988-05-24 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Treatment of diseases caused by viruses
US5159067A (en) * 1987-01-28 1992-10-27 University Of Georgia Research Foundation Inc. 5'-Diphosphohexose nucleoside pharmaceutical compositions
US4837311A (en) * 1987-06-22 1989-06-06 Hoffman-La Roche Inc. Anti-retroviral compounds
NZ228645A (en) * 1988-04-11 1991-09-25 Iaf Biochem Int 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
US5041449A (en) * 1988-04-11 1991-08-20 Iaf Biochem International, Inc. 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
EP0472595A4 (en) * 1989-05-15 1992-07-08 Us Commerce Method of treatment of hepatitis
US5071983A (en) * 1989-10-06 1991-12-10 Burroughs Wellcome Co. Therapeutic nucleosides
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
IT1249019B (it) * 1990-06-28 1995-02-11 Lamberti S P A L Emulsione acquosa di resine filmogene per la finitura di pelli, cuoio e croste di pelle e relativo procedimento di applicazione
DE69122264T2 (de) * 1990-11-13 1997-02-06 Biochem Pharma Inc., Laval, Quebec Substituierte 1,3-oxathiolane mit antiviralen eigenschaften
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
AU1787492A (en) * 1991-05-16 1992-12-30 Glaxo Group Limited Antiviral combinations containing nucleoside analogs

Also Published As

Publication number Publication date
GB9104740D0 (en) 1991-04-17
JP3442773B2 (ja) 2003-09-02
HUT72460A (en) 1996-04-29
IL101145A (en) 1996-08-04
JPH06506199A (ja) 1994-07-14
NZ241842A (en) 1994-08-26
ZA921660B (en) 1993-09-06
CA2105487A1 (en) 1992-09-07
KR100225986B1 (ko) 1999-10-15
CA2105487C (en) 2002-09-24
AU668860B2 (en) 1996-05-23
EP0574457B1 (en) 1999-10-13
DE69230140D1 (de) 1999-11-18
PT100199A (pt) 1993-07-30
AU1351292A (en) 1992-10-06
EP0574457A1 (en) 1993-12-22
GR3032299T3 (en) 2000-04-27
ES2138969T3 (es) 2000-02-01
CZ283185B6 (cs) 1998-01-14
HU9302496D0 (en) 1993-11-29
UA29429C2 (uk) 2000-11-15
ATE185483T1 (de) 1999-10-15
WO1992015309A1 (en) 1992-09-17
HU219492B (hu) 2001-04-28
US6107288A (en) 2000-08-22
CZ183693A3 (en) 1994-06-15
SK279767B6 (sk) 1999-03-12
SK95193A3 (en) 1994-01-12
IE920702A1 (en) 1992-09-09
US5234913A (en) 1993-08-10
MY108638A (en) 1996-10-31
RU2110993C1 (ru) 1998-05-20
HK1004189A1 (en) 1998-11-20
IL101145A0 (en) 1992-11-15
TW199861B (da) 1993-02-11
PT100199B (pt) 1999-06-30
DE69230140T2 (de) 2000-04-06

Similar Documents

Publication Publication Date Title
DK0574457T3 (da) Antiviral nucleosidkombination
ES2186667T3 (es) Analogos de nucleosidos de 1,3-oxatiolano.
RU93045710A (ru) Противовирусная нуклеозидная композиция, способ ее получения и способ лечения
DK224286A (da) 2',3'-dideoxy-nucleosider
ITBO910476A0 (it) -formulazioni farmeceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali.
ES2083668T5 (es) Combinaciones antiviricas que contienen analogos de nucleosido.
MY107843A (en) Anti-viral compounds.
MX9200361A (es) Nuevo uso del antagonista de adenosina.
DE3887014D1 (de) Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen.
IT1224594B (it) Impiego in terapeutica di derivati del 4h-benzo-4,5-cicloepta-1,2-bqti ofene
GR3024699T3 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections.
IT9019324A0 (it) Derivati del bilobalide,loro usi e formulazioni che li contegono
GB8822546D0 (en) Antiviral combinations
NO970178L (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
NO921563D0 (no) Terapeutisk aktive aminopyrimidinderivater, fremgangsmaatefor deres fremstilling og anvendelse derav
ATE57526T1 (de) P-acylaminobenzamide.
MX9303985A (es) Nucleosidos terapeuticos.
MY104976A (en) Antiviral compounds
MX9203485A (es) Derivados de tieno sulfonamida, composiciones farmaceuticas y uso.
ITRM920930A0 (it) Impiego del glutatione per la preparazione di composizioni farmaceutiche ad attivita' antivirale.